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Background
Oral immunotherapy (OIT) to cow milk protein (CMP)
allows some children with cow milk allergy (CMA) to
outgrow their allergy sooner, but increases their initial
risk of anaphylaxis.
Methods
We used Markov transition models to compare the
expected lifetime gain in quality-adjusted life years
(QALYs) of OIT to CMP versus strict avoidance of
CMP. Models were run for base cases of 6- to 16-year-
old children with CMA requiring strict CMP avoidance.
Rates of transition to the partial or full desensitization
and complete tolerance states, utilities for each state,
and disutilities and durations of reactions were deter-
mined from the literature. Participants progressed
through the OIT states in order but could regress to an
earlier state or repeat OIT.
Results
For an 8-year-old child, OIT resulted in a 0.9 QALYs
gain compared with strict avoidance; this benefit
increased to 1.9 QALYs for a 16-year-old. Sensitivity ana-
lysis showed that OIT became the preferred strategy
within 6 years of starting OIT. The models were sensitive
to the state utilities, but not to the transition probabilities
between states. Probabilities of reactions had to be over
10 times the literature-based estimates for OIT to no
longer be the preferred strategy. Limitations of these
models included the paucity of utility measures for chil-
dren with CMA and the possible under-reporting of
CMA-related reactions or death.
Conclusions
For children with CMA, OIT offers improved QALYs
and the benefits outweigh the risks within a few years.
Determination of utilities for younger children with
CMA will help to further address this question.
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